Does Secukinumab harm the body?

Secukinumab is a prescription medicine used to treat patients 6 years of age and older with moderate to severe plaque psoriasis and psoriatic arthritis (P Patients with sA), ankylosing spondylitis (AS), nonradiographic axial spondyloarthritis (nr-axSpA), and enthesitis-related arthritis (ERA) may be at increased risk of serious side effects because it is a drug that affects your immune system.

Secukinumab may reduce the immune system's ability to fight infection and may increase the risk of infection, sometimes serious. Before you start treatment with secukinumab, your doctor will test you for tuberculosis. If your doctor thinks you are at risk for tuberculosis, you may be given tuberculosis drugs before you start treatment with secukinumab and during your treatment with the medicine. Do not take secukinumab if you have active tuberculosis infection.

Secukinumab The original drug has been launched in China and has entered the scope of Class B medical insurance. However, domestic patients who can purchase this drug are limited to eligible patients with psoriasis and ankylosing spondylitis. Patients who are not eligible for medical insurance reimbursement can only purchase it at their own expense. The price of each box of 150mg/ML is about RMB 1,000. SecukinumabThe original drug has also been launched overseas. The specifications of the Turkish original versionThe price per box of 150mg/ML is about 1,500 yuan, and the European version is 150m. The price of each box of g/ML*2 is around RMB 15,000 (the price may fluctuate due to the exchange rate). The ingredients of foreign original drugs and domestic original drugs are basically the same. Currently, there are no generic secukinumab drugs on the market.